| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/17/2010 | US7776562 Reversible MHC multimer staining for functional purification of antigen-specific T cells |
| 08/17/2010 | US7776561 Use of specific T2R receptors to identify compounds that block bitter taste |
| 08/17/2010 | US7776560 Human tumor necrosis factor receptor TR9 antibody |
| 08/17/2010 | US7776558 Human G protein-coupled receptor and modulators thereof for the treatment of cell death-related disorders |
| 08/17/2010 | US7776552 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/17/2010 | US7776548 Endocytotic pathway delivery vehicle for targeting drugs and antibodies to prostate and other tissues |
| 08/17/2010 | US7776546 Using immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics |
| 08/17/2010 | US7776534 Episomal fusion gene |
| 08/17/2010 | US7776528 Radiative decay engineering |
| 08/17/2010 | US7776526 conatacting an extracellular haemoglobin sample from annelids with dissociating agent e.g. a mixture containing dithiothreitol (DTT) or tris(2-carboxyethyl)phosphine (TCEP) hydrochloride or beta-mercaptoethanol and a dissociation buffer for a sufficient length of time in order to separate the chains |
| 08/17/2010 | US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH) |
| 08/17/2010 | US7776518 Detection of survivin in the biological fluids of cancer patients |
| 08/17/2010 | US7776361 NELL-1 enhanced bone mineralization |
| 08/17/2010 | US7776340 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43 |
| 08/17/2010 | US7776337 novel lactic acid-producing strains; Lactobacillus acidophilus; for use in therapeutic feeds, reducing levels of colonization by target bacteria in poultry |
| 08/17/2010 | US7776336 Compositions comprising Yersinia pestis antigens |
| 08/17/2010 | US7776335 Microorganismal enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection |
| 08/17/2010 | US7776334 administering hematopoietic cells to increase blood platelet; for patient receiving cancer chemotherapy or radiation therapy, or immunosuppressants; treating blood disorders anemia, myeloma, non-Hodgkin's lymphoma, Hodgkins lymphoma and leukaemia |
| 08/17/2010 | US7776333 Obtained from fraction(s) precipitated by ammonium sulfate precipitation using an aqueous extract from Pleurotus cornucopiae; protein has an antifungal activity against rice blast; genetic engineering |
| 08/17/2010 | US7776323 Streptococcus suis vaccines and diagnostic tests |
| 08/17/2010 | US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 08/17/2010 | CA2506580C Assay kit and antibody for human low molecular weight cd14 |
| 08/17/2010 | CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 08/17/2010 | CA2440424C Novel protein isolated from pleurotus cornucopiae |
| 08/17/2010 | CA2420990C Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
| 08/17/2010 | CA2395431C Separation of fibrinogen from plasma proteases |
| 08/17/2010 | CA2318571C Methods of controlling cell differentiation and growth using a fusion protein and a drug |
| 08/17/2010 | CA2314396C High expression escherichia coli expression vector |
| 08/17/2010 | CA2310726C Plant seedling and embryo promoter |
| 08/17/2010 | CA2271955C Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses |
| 08/17/2010 | CA2269634C Reagents and methods useful for detecting diseases of the breast |
| 08/17/2010 | CA2224153C Radiolabeled peptide compositions for site-specific targeting |
| 08/17/2010 | CA2222679C Separating unmodified hemoglobin from cross-linked hemoglobin |
| 08/17/2010 | CA2203679C Oral immunization with transgenic plants |
| 08/17/2010 | CA2169260C Gene therapy for solid tumors, papillomas and warts |
| 08/13/2010 | CA2654108A1 Methods for treating septic shock |
| 08/12/2010 | WO2010091328A1 Diagnostic and therapeutic uses of gnptab, gnptg, and nagpa in stuttering |
| 08/12/2010 | WO2010091265A1 Compounds and methods for treating viral encephalitis |
| 08/12/2010 | WO2010091262A1 Chimeric newcastle disease viruses and uses thereof |
| 08/12/2010 | WO2010091230A1 Variant axmi-r1 delta-endotoxin genes and methods for their use |
| 08/12/2010 | WO2010091122A1 Extended recombinant polypeptides and compositions comprising same |
| 08/12/2010 | WO2010090873A2 Polypeptides and their use as adjuvants |
| 08/12/2010 | WO2010090834A2 Netrin-1 as a biomarker of injury and disease |
| 08/12/2010 | WO2010090758A2 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods |
| 08/12/2010 | WO2010090523A1 Truncated cystine-knot proteins |
| 08/12/2010 | WO2010090318A1 Coelenteramide analogs |
| 08/12/2010 | WO2010089554A1 Peptides for vaccine |
| 08/12/2010 | WO2010089412A1 Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof |
| 08/12/2010 | WO2010089402A1 Splitting gp41 |
| 08/12/2010 | WO2010089400A1 Novel gp41 antigens |
| 08/12/2010 | WO2010089385A1 Purification process |
| 08/12/2010 | WO2010089340A2 Peptides protective against e. faecalis, methods and uses relating thereto |
| 08/12/2010 | WO2010089129A1 Inhibitors of viral fusion and uses thereof |
| 08/12/2010 | WO2010089120A1 Novel method for the manufacturing of neurotoxins |
| 08/12/2010 | WO2010088857A1 Crystal structure of amino terminal portion of influenza virus polymerase pa subunit and use thereof |
| 08/12/2010 | WO2010088803A1 New porcine reproductive and respiratory syndrome virus receptor, and blockers thereof |
| 08/12/2010 | WO2010088778A1 Cd109 polypeptides and uses thereof for the treatment of skin cells |
| 08/12/2010 | WO2010088729A1 Compositions and uses therefor |
| 08/12/2010 | WO2010069570A3 Peptides against autoantibodies associated with crps and use of these peptides |
| 08/12/2010 | WO2010066418A8 Use of flt3 ligand for strengthening immune responses in rna immunization |
| 08/12/2010 | WO2010053320A3 Method for delivering cargoes into cells, and peptide for same |
| 08/12/2010 | WO2010033319A3 Novel bacillus thuringiensis gene with lepidopteran activity |
| 08/12/2010 | WO2010013012A9 Hypothermia inducing polypeptides and uses thereof |
| 08/12/2010 | WO2010003032A3 Recombinant human parainfluenza type 1 viruses (hpiv1s) containing mutations in or deletion of the c protein are attenuated in african green monkeys and in ciliated human airway epithelial cells and are potential vaccine candidates for hpiv1 |
| 08/12/2010 | WO2009143367A3 Egf-a domain-mediated modulation of pcsk9 for treating lipid disorders |
| 08/12/2010 | US20100205695 Promoters for regulation of gene expression in plant roots |
| 08/12/2010 | US20100205693 Promoters for regulation of gene expression in plant roots |
| 08/12/2010 | US20100205690 Plants With Increased Yield |
| 08/12/2010 | US20100205681 Prognostic marker for breast cancer and composition for inducing obesity comprising hccr-1 |
| 08/12/2010 | US20100204458 Process for the Production of Immunogenic Compositions |
| 08/12/2010 | US20100204453 Antibodies to tumor associated proteins |
| 08/12/2010 | US20100204451 Insulinotropic peptide derivative wherein its n-terminal amino acid is modified |
| 08/12/2010 | US20100204449 Methods and intermediates for chemical synthesis of polypeptides and proteins |
| 08/12/2010 | US20100204447 Use of anitmicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| 08/12/2010 | US20100204446 Use of natriuretic peptides for treating angioedema syndromes |
| 08/12/2010 | US20100204445 Dockerin polypeptide and method of purifying recombinant fused protein using the same |
| 08/12/2010 | US20100204442 Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof |
| 08/12/2010 | US20100204308 Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy |
| 08/12/2010 | US20100204304 NOGO Receptor Binding Protein |
| 08/12/2010 | US20100204297 Influenza therapeutic |
| 08/12/2010 | US20100204253 Ribosome Structure and Protein Synthesis Inhibitors |
| 08/12/2010 | US20100204120 Trimeric hiv fusion inhibitors for treating or preventing hiv infection |
| 08/12/2010 | US20100204116 Use of calcitonin as anti-angiogenic agent |
| 08/12/2010 | US20100204113 Use of stresscopin-related peptide as a therapeutic agent |
| 08/12/2010 | US20100204107 Use of urodilatin as a therapeutic agent |
| 08/12/2010 | US20100204105 Glucagon analogues |
| 08/12/2010 | US20100204104 Fusion proteins containing two tgf-beta binding domains of tgf-beta type ii receptor |
| 08/12/2010 | US20100204103 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 08/12/2010 | US20100204100 Biological agents active in central nervous system |
| 08/12/2010 | US20100204098 Peptides with antifungal activity |
| 08/12/2010 | US20100204097 Therapeutic methods using a thymus peptide |
| 08/12/2010 | US20100204095 Genetically Modified TFPI And Method Of Making The Same |
| 08/12/2010 | US20100204094 Diuretic and natriuretic polypeptides |
| 08/12/2010 | US20100204092 Activin-actrii antagonists and uses for increasing red blood cell levels |
| 08/12/2010 | US20100204091 SIVA Ubiquitination and/or Degradation-Related Activity and Modulators Thereof |
| 08/12/2010 | US20100204087 Tribonectins |
| 08/12/2010 | US20100204052 Protein scaffolds and uses thereof |
| 08/12/2010 | US20100204051 Hereditary Hemochromatosis Gene |
| 08/12/2010 | US20100203653 Protein G-Oligonucleotide Conjugate |
| 08/12/2010 | US20100203634 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by Wnt factors |